Infectious diseases
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
110
NCT05735249
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 9, 2023
Completion: Mar 28, 2025
NCT06911242
A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions
Start: Mar 17, 2025
Completion: Apr 21, 2025
Loading map...